换一批
换一批Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].
作者：
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);皮肤科用药(Dermatologic Agents);健康调查(Health Surveys);人类(Humans);免疫因子类(Immunologic Factors);注射, 皮下(Injections, Subcutaneous);中年人(Middle Aged);瘙痒症(Pruritus);银屑病(Psoriasis);生活质量(Quality of Life);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
DOI
10.1186/1471-5945-5-13
PMID
16359548
发布时间
2019-12-10
- 浏览21
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
